103 related articles for article (PubMed ID: 68700)
1. Discussion paper: effect of supernatants from long-term lymphoid cell lines on metastatic cutaneous tumors following local injection.
Papermaster BW; Holtermann OA; McDaniel MC; Klein E; Djerassi I; Rosner D; Dao T; Costanzi JJ
Ann N Y Acad Sci; 1976; 276():584-91. PubMed ID: 68700
[TBL] [Abstract][Full Text] [Related]
2. Lymphokine properties of a lymphoid cultured cell supernatant fraction active in promoting tumor regression.
Papermaster BW; Holtermann OA; Klein E; Parmett S; Dobkin D; Laudico R; Djerassi I
Clin Immunol Immunopathol; 1976 Jan; 5(1):48-59. PubMed ID: 1083321
[No Abstract] [Full Text] [Related]
3. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
Postlethwaite AE; Kang AH
J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
[TBL] [Abstract][Full Text] [Related]
4. The production of anti-guinea pig lymphokine antibody.
Yoshida T; Bigazzi PE; Cohen S
J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
[TBL] [Abstract][Full Text] [Related]
5. Preliminary observations on tumor regressions induced by local administration of a lymphoid cell culture supernatant fraction in patients with cutaneous metastatic lesions.
Papermaster BW; Holtermann OA; Klein E; Djerassi I; Rosner D; Dao T; Costanzi JJ
Clin Immunol Immunopathol; 1976 Jan; 5(1):31-47. PubMed ID: 1261098
[No Abstract] [Full Text] [Related]
6. Lymphokine-mediated immunotherapy studies in mouse tumor systems.
Papermaster BW; Gilliland CD; McEntire JE; Smith ME; Buchok SJ
Cancer; 1980 Mar; 45(5 Suppl):1248-53. PubMed ID: 7357517
[TBL] [Abstract][Full Text] [Related]
7. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
[TBL] [Abstract][Full Text] [Related]
8. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
Gately MK; Gately CL; Henney CS; Mayer MM
J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
[TBL] [Abstract][Full Text] [Related]
9. Amplified migration inhibition effect.
Philp JR; Huffman AL; DeChatelet LR; Johnson JE
Infect Immun; 1980 Aug; 29(2):609-16. PubMed ID: 7011979
[TBL] [Abstract][Full Text] [Related]
10. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
Piessens WF; Churchill WH; David
J Immunol; 1975 Jan; 114(1 Pt 2):293-9. PubMed ID: 163856
[TBL] [Abstract][Full Text] [Related]
11. Subpopulations of lymphocytes to produce various lymphokines. I. Function of subpopulations separated by velocity sedimentation.
Doroszczak N; Yoshida T; Cohen S
J Immunol; 1977 Nov; 119(5):1617-20. PubMed ID: 334967
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
Sorg C; Geczy CL
Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
[TBL] [Abstract][Full Text] [Related]
13. [Lymphokine production in the cell-mediated immune response (author's transl)].
Chou CS; Han SH
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Sep; 10(3):51-9. PubMed ID: 580234
[TBL] [Abstract][Full Text] [Related]
14. Association of macrophage-activation factor from a human cultured lymphoid cell line with albumin and alpha2-macroglobulin.
McDaniel MC; Laudico R; Papermaster BW
Clin Immunol Immunopathol; 1976 Jan; 5(1):91-104. PubMed ID: 57021
[No Abstract] [Full Text] [Related]
15. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
Geczy CL; Geczy AF; De Weck AL
J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
[TBL] [Abstract][Full Text] [Related]
16. Desensitization: effects on cutaneous and peritoneal manifestations of delayed hypersensitivity in relation to lymphokine production.
Sonozaki H; Papermaster V; Yoshida T; Cohen S
J Immunol; 1975 Dec; 115(6):1657-61. PubMed ID: 1102607
[TBL] [Abstract][Full Text] [Related]
17. Regulation of macrophage agglutination factor production by alpha 2-macroglobulin.
Godfrey HP; Atlas A; Randazzo B; Angadi CV
Immunology; 1984 Mar; 51(3):503-10. PubMed ID: 6199293
[TBL] [Abstract][Full Text] [Related]
18. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
[TBL] [Abstract][Full Text] [Related]
19. A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity.
Rouveix B; Badenoch-Jones P; Turk JL
Immunology; 1979 Mar; 36(3):589-94. PubMed ID: 374256
[TBL] [Abstract][Full Text] [Related]
20. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
Ruthlomnitzer ; Rabson AR; Koornhof HJ
Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
